Product Information
GABAPENTIN 800 MG TABLET is a generic product labeled by Mullan Pharmaceutical Inc., priced at $0.0900 per EA under NDC 83301000202. Its NADAC has been published 54 times since Aug 13, 2025.
FDA first approved this application on Oct 26, 2017. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
800 mg/1
Manufacturer
Mullan Pharmaceutical Inc.NDC
83301000202
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA207057FDA Approved
10/26/2017
TE Code
AB1
On Market Since
1/1/2024
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 800 MG TABLET has been published 54 times since Aug 13, 2025, and over the history we have for it it has declined 11.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0900 per EA |
|---|---|
| All-time high | $0.1029 (Sep 10, 2025) |
| All-time low | $0.0900 (Aug 19, 2026) |
| 52-week high | $0.1029 |
| 52-week low | $0.0900 |
| Median price | $0.0995 |
| Average price | $0.0992 |
| Largest weekly change | -4.0% (Aug 19, 2026) |
| Weeks tracked | 54 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
The matcher finds 21 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GABAPENTIN 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 800 MG TABLET, manufactured by Mullan Pharmaceutical Inc., is $0.0900 per EA (NDC 83301000202), effective Aug 19, 2026.
How has the price of GABAPENTIN 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 800 MG TABLET has declined 11.5%. It has been tracked across 54 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 800 MG TABLET?
Since Aug 13, 2025, the NADAC for GABAPENTIN 800 MG TABLET has ranged from a low of $0.0900 (Aug 19, 2026) to a high of $0.1029 (Sep 10, 2025), with a median of $0.0995 per EA.
Are there cheaper alternatives to GABAPENTIN 800 MG TABLET?
21 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GABAPENTIN 800 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GABAPENTIN 800 MG TABLET?
GABAPENTIN 800 MG TABLET (NDC 83301000202) is labeled by Mullan Pharmaceutical Inc., and CMS classifies it as a generic product.